Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The...
Vous n'êtes pas connecté
Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The investment will support Aragen’s strategic expansion and infrastructure development to meet growing demand for outsourcing services from US and Europe innovators. This move positions Aragen strongly in the pharmaceutical outsourcing market, enhancing its capabilities and accelerating program delivery.
Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The...
Telangana-based nutraceutical company, Botanic Healthcare today announced that it has raised ₹250 crore (approximately $30 million) in a fresh...
ACWA Power Co. has secured funding of 2.6 billion Saudi riyals ($692.05 million) for a 1,100 megawatt (MW) wind power plant in Suez, Egypt. The...
The U.S. Department of Justice (DOJ) allocated over $100 million between 2021 and 2024 to education programs promoting restorative justice, social...
The U.S. Department of Justice (DOJ) allocated over $100 million between 2021 and 2024 to education programs promoting restorative justice, social...
[Lagos, Nigeria – January 06, 2025] – Guaranty Trust Holding Company Plc (“GTCO Plc” or the “Group”) (NGX: GTCO) is pleased to...
ACWA Power has secured SR2.63 billion ($703 million) in financing to develop, operate, and maintain a 1,100-megawatt wind power plant in Egypt’s...
Qvantum, a Skåne-based company specializing in advanced heat pump systems and grid services, has raised €108 million in a Series C funding round....